The company faces ongoing securities litigation with serious allegations of patient detention without medical necessity, patient abuse, and fraudulent insurance billing. The court's denial of the motion to dismiss allows the case to proceed, increasing litigation risk and potential financial liability. Stock price declined significantly following investigative reporting and government inquiries.
Stock down 22% over the past year with significant underperformance versus S&P 500. Company recorded a $996.2 million goodwill impairment, elevated net leverage at 4.0x adjusted EBITDA, declining adjusted EBITDA despite revenue growth, and a major fund exit signals loss of investor confidence. Multiple operational and financial headwinds persist.
Articles that tag ACHC but are mainly about other companies.
Stock rose 7.1% on multiple analyst upgrades with higher price targets citing stronger first-quarter volumes
Identified as a key market player in a sector experiencing strong growth driven by rising mental health disorder prevalence and increasing demand for behavioral health services across multiple care settings.
Up 23.8%, among top gainers on the day.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
